Novartis in deal to sell diagnostics unit

GENEVA (AP) Pharmaceutical company Novartis says it is selling part of its diagnostics business to the Spanish health care company Grifols for $1.68 billion.

The company, based in Basel, Switzerland, says the deal with Grifols SA, which is headquartered in Barcelona and is the world's third-largest producer of plasma-derived therapies, requires customary regulatory approvals but is expected to be completed in the first half of 2014.

Joseph Jimenez, the CEO of Novartis, said in a statement Monday the sale of the company's blood transfusion diagnostics unit "enables us to focus more sharply on our strategic businesses while providing Grifols with a platform for global expansion."

Novartis AG says the unit it acquired in 2006 as part of Chiron, an Emeryville, California-based biotech company, had sales of $565 million in 2012.

This story has been automatically published from the Associated Press wire which uses US spellings

Get the news delivered straight to your inbox

Receive the day’s news, sport and entertainment in our daily email newsletter


© Copyright 2015, NZME. Publishing Limited

Assembled by: (static) on production apcf01 at 02 Dec 2015 08:05:06 Processing Time: 353ms